NASDAQ:AIMT - Aimmune Therapeutics, Inc.
$24.10
 $0.52
+2.21%
1:55PM EDT
2019-02-15
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. The Company's therapeutic approach, which it refers to as Characterized Oral Desensitization Immunotherapy (CODIT), is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols and support services. The Company's lead CODIT product candidate, AR101, is an investigational biologic for the treatment of patients with peanut allergy. The Company has initiated Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE), its Phase III registration trial of AR101. The Company is in the process of evaluating additional delivery forms for AR101 for the maintenance phase. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  AIMT     avg for
industry  
  avg for
sector  
42 stocks weight:  52. 16   0. 00   0. 00  
42 stocks rank:  2. 68 K 1. 86 K 1. 09 K
# analyst opinions:  11. 00   14. 92   14. 43  
mean recommendation:  1. 90   1. 91   1. 93  

quick ratio:  6. 82   5. 37   1. 81  
current ratio:  6. 99   5. 69   2. 19  

target price low:  25. 46   88. 97   117. 82  
target price avg:  33. 00   115. 19   141. 96  
target price high:  53. 27   143. 40   163. 16  
1-yr high:  37. 20   124. 30   142. 77  
last close:  23. 58   101. 85   127. 84  
50-day avg:  23. 56   98. 27   122. 46  
200-day avg:  27. 33   99. 72   122. 70  
1-yr low:  21. 69   78. 19   100. 16  
volume:  539. 53 K 2. 38 M 4. 64 M
50-day avg volume:  683. 76 K 3. 31 M 4. 94 M
200-day avg volume:  550. 69 K 3. 23 M 4. 28 M

1-day return:  -0. 97 % 0. 22 % 0. 48 %
this week return:  -4. 19 % 1. 77 % 2. 01 %
12-wk return:  -7. 71 % 6. 56 % 3. 33 %
52-wk return:  -37. 14 % -2. 23 % 14. 35 %

enterprise value (EV):  1. 19 B 55. 17 B 104. 51 B
market cap:  1. 46 B 49. 01 B 96. 46 B
EBITDA:  -197. 16 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -6. 04   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -194. 92 M 2. 37 B 3. 58 B

shares outstanding:  61. 97 M 607. 99 M 1. 22 B
shares:  37. 33 M 605. 53 M 1. 15 B
shares short:  6. 41 M 11. 62 M 12. 55 M
shares short prior month:  5. 78 M 11. 95 M 13. 44 M
short ratio:  7. 10   4. 82   3. 10  
short % of float:  14. 97 % 6. 19 % 2. 82 %
total cash/share:  4. 35   12. 02   11. 46  
total cash:  255. 25 M 7. 41 B 7. 37 B
free cash flow:  -86. 89 M 95. 99 M 2. 04 B
operating cash flow:  -149. 50 M 164. 74 M 3. 04 B

book value:  4. 21   14. 43   28. 26  
price/book:  5. 60   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  16. 29 % --- ---
1-yr mean volatility:  -0. 13 % 0. 01 % 0. 06 %

1-yr EPS:  -3. 53   3. 03   4. 09  
forward EPS:  -3. 45   4. 33   6. 99  
P/E:  -6. 67   6. 11   26. 91  
forward P/E:  -7. 13   8. 38   10. 48  
PE/G:  0. 81   0. 37   5. 61  
growth:  -8. 28 % 683. 72 % 104. 79 %
earnings high:  -0. 73   1. 27   1. 66  
earnings avg:  -0. 91   1. 01   1. 53  
earnings low:  -1. 07   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -47. 62 % -3. 27 % 3. 81 %
return on equity:  -85. 16 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  0. 88   1. 21   0. 93  
sharpe (1yr):  -0. 62   0. 06   0. 98  

held % insiders:  20. 21 % 6. 46 % 3. 21 %
held % institutions:  81. 52 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : AIMT
.    + 1.322 =         1.322 :: INITIAL WEIGHT
.  + 132.437 =       133.759 :: inverse volume-to-price addition
.  + 407.027 =       540.786 :: spline projection addition
.   - 128.82 =       411.966 :: poor performance penalty
.    x 0.767 =       316.016 :: one-year gains+dividend factor
.    x 4.896 =      1547.351 :: 13 weeks' performance factor
.    x 1.492 =      2309.405 :: industry recommendation factor
.    x 2.432 =      5615.739 :: symbol recommendation factor
.    x 0.995 =      5588.995 :: return on assets factor
.    x 0.991 =      5541.397 :: return on equity factor
.    x 2.772 =     15362.404 :: current ratio factor
.    x 1.083 =     16630.748 :: quick ratio factor
.    x 1.068 =      17763.36 :: short ratio factor
.    x 2.092 =     37163.723 :: price-to-book factor
.    x 1.026 =     38126.102 :: 5-day avg > 50-day avg
.    x 2.133 =     81319.564 :: P/E weight
.    x 1.055 =     85831.552 :: PE/G factor
.    x 1.668 =    143186.626 :: beta factor
.    x 0.623 =     89194.042 :: sharpe factor
.    x 1.284 =    114519.966 :: target low factor
.    x 1.211 =    138647.531 :: target mean factor
.    x 1.112 =    154205.229 :: target high factor
.    x 1.066 =    164323.067 :: industry 12-weeks return
.    x 0.996 =    163686.768 :: "drift" penalty 3 days ago
.    x 0.936 =    153224.758 :: "drift" penalty 4 days ago
.    x 0.998 =    152950.433 :: overall "drift" factor
.    x 0.837 =    128034.129 :: largest single-day jump factor
.     x 1.01 =    129312.754 :: mean volatility factor
.    x 1.097 =    141895.306 :: 42-day mean volatility factor
.      x 1.0 =    141904.831 :: factor hist industry gain for week 06
.   cubeRoot =        52.159 :: reduced for readability
.                     52.159 :: FINAL WEIGHT for NASDAQ:AIMT


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org